Johnson & Johnson deserves more credit for another healthy quarter and strong guidance
The new year has been tough on pharmaceutical stocks, including JNJ. But it should not be read as an indictment
Read More
Jim Cramer
Jim Cramer’s top 10 things to watch in the market Tuesday: Club earnings, AMD downgrade, Disney hope
Big day of earnings for Club holdings as the Dow, S&P 500 and Nasdaq look to open lower after back-to-back
Read More
Jim Cramer says these 6 ‘positives’ could help lift stocks during earnings season
Jim Cramer went over six factors that could help buoy stocks during the upcoming earnings season. Source link
Read More
Bullish analyst note gives troubled chipmakers a much needed boost. Here’s our view
Barclays on Monday published its December-quarter earnings preview and 2023 outlook note that was particularly kind to our semiconductor holdings.
Read More
Get ready for a deluge of data next week that will shape the Fed’s next moves
These are the key economic reports and earnings results to watch. Source link
Read More
Jim Cramer names 6 e-commerce plays that are buys, says to wait on Amazon
"There are still some e-commerce plays that I'm willing to get behind here, the ones that have truly prioritized profitability,"
Read More
Cramer’s week ahead: ‘Be on your toes’ this earnings period
Jim Cramer previewed next week's slate of earnings featuring reports from Microsoft, Southwest Airlines, IBM and more. Source link
Read More
Jim Cramer’s top 10 things to watch in the market Friday: Google job cuts, Netflix delivers
Alphabet shares bucked the sharp back-to-back downdraft in the Nasdaq, and they're up more than 3.5% early Friday. Source link
Read More
Morgan Stanley CEO says the bank’s push for more stable revenue streams has worked. It’s a key reason we own the stock
Morgan Stanley's multiyear pivot toward wealth and asset management has been a success, CEO James Gorman told CNBC. Source link
Read More